Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LOSARTAN | 50.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71074 |
| MINT-LOSARTAN | 50.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113187 |
| MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113190 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80808 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147784 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-10-21 | 2023-04-01 | 147787 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147790 |
| MINT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-04-12 | 2018-05-04 | 45542 |
| MINT-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122521 |
| MINT-OLANZAPINE | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122524 |
| MINT-OLANZAPINE | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122527 |
| MINT-ONDANSETRON | 4MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27164 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
| MINT-OSELTAMIVIR | 75MG | CAPSULE | Actual shortage | 2022-01-05 | 2023-01-03 | 152092 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-10-17 | 45121 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-08-22 | 45124 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-03 | 2019-02-07 | 71078 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-04-08 | 2019-07-19 | 80814 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-09 | 2019-11-16 | 95919 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |